A Narrative Review of Novel Agents for Managing Heavily Treatment-Experienced People Living With HIV.
Objective: The objective of this review is to compare ibalizumab, fostemsavir, and lenacapavir, present the clinical trials evaluating each agent, and provide guidance on their use in highly-treatment experienced (HTE) population living with HIV (PWH). Data sources: A search of PubMed and clinicaltr...
| Publicado en: | Journal of Pharmacy Technology Vol. 40; no. 4; pp. 194 - 202 |
|---|---|
| Autores principales: | , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
Aug2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |